Clinical Trials · NCT05984238
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Enrollment
- 33
- Start date
- Aug 2023
- Locations
- 1 site, Netherlands
- Primary endpoint
- Incidence rate of procedure-related SAEs, UADEs, SADEs, AESIs [safety]